APA (7th ed.) Citation

Wang, F., Zhao, F., Zhang, L., Xiong, L., Mao, Q., Liu, Y., . . . Liu, L. (2022). CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma. Molecular Cancer, 21(1), 1. https://doi.org/10.1186/s12943-022-01623-8

Chicago Style (17th ed.) Citation

Wang, Feng, et al. "CDC6 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma." Molecular Cancer 21, no. 1 (2022): 1. https://doi.org/10.1186/s12943-022-01623-8.

MLA (9th ed.) Citation

Wang, Feng, et al. "CDC6 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma." Molecular Cancer, vol. 21, no. 1, 2022, p. 1, https://doi.org/10.1186/s12943-022-01623-8.